Original Articles
Inborn errors of metabolism in the Italian pediatric population: A national retrospective survey

https://doi.org/10.1067/mpd.2002.122394Get rights and content

Abstract

Objective: To estimate at the national level the overall and diseasespecific incidence of inborn errors of metabolism not mass screened at birth. Study design: Prospective nonconcurrent study (1985-1997) on patients 0 to 17 years of age, diagnosed in 23 Italian pediatric reference centers. Results: Cases (n = 1935) were recruited representing an incidence of 1:3707 live births for ∼200 diseases. In the last 5 years the incidence was 1:2758, reflecting improved diagnostic facilities, better coverage, increased medical awareness, and newly discovered diseases. In this period, the most frequent classes of diseases were lysosomal storage disease, 1:8275; disorders of carbohydrate metabolism, 1:19,532; organic acidopathies, 1:21,422; and primary lactic acidemias, 1:27,106. The most frequent individual diseases were Gaucher type I, 1:40,247; glycogenosis type 1a, 1:57,746; methylmalonic acidurias, 1:61,775; and ornithine transcarbamylase deficiency, 1:69,904. The incidence of diseases potentially identifiable with the use of a new neonatal mass screening technique is 1:6200. Of surviving patients, 11% reached adulthood by the end of the study. Conclusions: Inborn errors of metabolism constitute a highly heterogeneous category of rare diseases, representing a relevant cause of morbidity and mortality in childhood. This study quantifies the minimum size of the disease burden, providing useful tools for public health and health policy planning. (J Pediatr 2002;140:321-7)

References (0)

Cited by (189)

  • Extended Risk of Mortality in Children with Inborn Errors of Metabolism: A Longitudinal Cohort Study

    2023, Journal of Pediatrics
    Citation Excerpt :

    An Australian cross-sectional study of death records from 120 children with inborn errors found that disorders of intermediary and energy metabolism were principal causes of neonatal death, and most deaths between 1 and 14 years were due to lysosomal storage and energy metabolism disorders.4 An Italian investigation of 1935 children noted that most deaths before 18 years were due to primary lactic acidemias and peroxisomal or lysosomal disorders, although the specific age of death was not reported.10 In our cohort, disorders of mineral metabolism exhibited the greatest risk of mortality within 28 days of life, whereas disorders of sphingolipid metabolism were associated with the greatest risk between age 1 and 14 years.

  • Newborn screening for Pompe disease in Italy: Long-term results and future challenges

    2022, Molecular Genetics and Metabolism Reports
    Citation Excerpt :

    The overall incidence of PD from our NBS data was 1 in 18,795 (IOPD 1 in 68,914; LOPD 1 in 25,843). The reported clinical prevalence of PD worldwide is 1 in 40,000 [49], whilst a previous Italian study estimated an incidence of 1:120,743 [50]. The difference with our results could be explained by the recent immigration from Africa (4/11 patients), where there is a higher incidence of consanguinity (2/4 our patients, pt.4 and pt.25), but also by the identification of a high number of LOPD patients.

View all citing articles on Scopus

Supported by the Italian Ministry of Health, grant ICS 120.2/RF96.349.

View full text